Skip to main content
. 2019 Jun 30;45(2):204–209. doi: 10.12865/CHSJ.45.02.12

Figure 1.

Figure 1

A. Well differentiated CRC, E-cadherin immunostaining, x100; B. Low differentiated CRC, E-cadherin immunostaining, x100; C. Cases distribution depending on E-cadherin scores and grading; D. Cases distribution depending on E-cadherin scores and tumor stage